Yiu‐Lam Kwan

930 total citations · 1 hit paper
15 papers, 661 citations indexed

About

Yiu‐Lam Kwan is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Yiu‐Lam Kwan has authored 15 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Hematology. Recurrent topics in Yiu‐Lam Kwan's work include Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yiu‐Lam Kwan is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Yiu‐Lam Kwan collaborates with scholars based in Australia, Canada and New Zealand. Yiu‐Lam Kwan's co-authors include Brad S. Kahl, David MacDonald, Regina Clementi, Mihaela Munteanu, Ian W. Flinn, Samar Issa, John M. Burke, Peter Wood, Mark Hertzberg and Michael Craig and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Pathology.

In The Last Decade

Yiu‐Lam Kwan

15 papers receiving 653 citations

Hit Papers

Randomized trial of bendamustine-rituximab or R-CHOP/R-CV... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
    2014 419 citations Ian W. Flinn, Richard van der Jagt et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiu‐Lam Kwan Australia 7 458 438 240 101 89 15 661
Paul‐André Bryon France 14 509 1.1× 338 0.8× 265 1.1× 85 0.8× 81 0.9× 18 687
Jens Krugmann Austria 18 432 0.9× 402 0.9× 229 1.0× 82 0.8× 156 1.8× 41 857
Karin E. Summers United Kingdom 9 404 0.9× 280 0.6× 251 1.0× 163 1.6× 138 1.6× 11 608
Suguru Fukuhara Japan 14 433 0.9× 260 0.6× 183 0.8× 68 0.7× 65 0.7× 83 603
Matteo Dell’Olio Italy 14 378 0.8× 274 0.6× 286 1.2× 83 0.8× 77 0.9× 30 624
Martin Dreyling Germany 13 470 1.0× 344 0.8× 226 0.9× 50 0.5× 89 1.0× 28 622
Flora N. Kontopidou Greece 17 427 0.9× 216 0.5× 255 1.1× 81 0.8× 86 1.0× 37 615
Olivier Fitoussi France 13 614 1.3× 475 1.1× 217 0.9× 162 1.6× 120 1.3× 43 870
J Pierson United States 12 519 1.1× 340 0.8× 242 1.0× 125 1.2× 41 0.5× 13 651
Emmanuelle Nicolas‐Virelizier France 13 424 0.9× 285 0.7× 195 0.8× 56 0.6× 54 0.6× 58 585

Countries citing papers authored by Yiu‐Lam Kwan

Since Specialization
Citations

This map shows the geographic impact of Yiu‐Lam Kwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiu‐Lam Kwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiu‐Lam Kwan more than expected).

Fields of papers citing papers by Yiu‐Lam Kwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiu‐Lam Kwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiu‐Lam Kwan. The network helps show where Yiu‐Lam Kwan may publish in the future.

Co-authorship network of co-authors of Yiu‐Lam Kwan

This figure shows the co-authorship network connecting the top 25 collaborators of Yiu‐Lam Kwan. A scholar is included among the top collaborators of Yiu‐Lam Kwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiu‐Lam Kwan. Yiu‐Lam Kwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Krishnan, Sabna Rajeev, Frederick Luk, Ross Brown, et al.. (2016). Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma. Neoplasia. 18(1). 25–32. 53 indexed citations
2.
Webster, Bradley R., Kenneth Lee, Judith Trotman, et al.. (2015). Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn’s disease. World Journal of Gastroenterology. 21(19). 6072–6076. 51 indexed citations
3.
Trotman, Judith, Peter J. Shaw, Campbell Tiley, et al.. (2015). Evaluation of Pharmacokinetic-Based Dose Predictions of High Dose Melphalan in Patients with Myeloma. Blood. 126(23). 4314–4314. 2 indexed citations
4.
Flinn, Ian W., Richard van der Jagt, Brad S. Kahl, et al.. (2014). Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood. 123(19). 2944–2952. 419 indexed citations breakdown →
5.
6.
MacDonald, David, Richard van der Jagt, John M. Burke, et al.. (2013). Different safety profiles of first-line bendamustine-rituximab (BR), R-CHOP, and R-CVP in an open-label, randomized study of indolent non-Hodgkin lymphoma (NHL) and mantle cell lymphoma (MCL): The BRIGHT study.. Journal of Clinical Oncology. 31(15_suppl). 8565–8565. 2 indexed citations
7.
8.
9.
Diamond, Terrence, Terry Golombick, A. Manoharan, Yiu‐Lam Kwan, & Carl Bryant. (2011). The impact of osteoporosis (as measured by lumbar spine quantitative computed tomography) on disease activity and survival in myeloma patients: A 13‐year prospective study. American Journal of Hematology. 86(7). 617–619. 5 indexed citations
10.
Diamond, T., et al.. (1997). Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: effects of glucocorticoid therapy and disease activity. British Journal of Haematology. 97(3). 641–648. 55 indexed citations
11.
Markovic, Boban, et al.. (1992). A sensitive method for the detection of poly‐A tails of mRNA using a biotin‐labelled heteropolymer OF dT:rA. The Journal of Pathology. 167(4). 369–373. 12 indexed citations
12.
Kwan, Yiu‐Lam, et al.. (1991). An improved method of alkaline phosphatase — antialkaline phosphatase immunophenotyping using microwave irradiation. Pathology. 23(3). 268–270. 3 indexed citations
13.
Kwan, Yiu‐Lam, et al.. (1990). Trisomy 4 in a case of acute biphenotypic leukemia. Cancer Genetics and Cytogenetics. 47(2). 265–269. 16 indexed citations
14.
Vowels, Marcus R., P.R.L.C. Lam-Po-Tang, David Ford, et al.. (1986). Bone‐marrow transplantation for haematological malignancy in childhood. The Medical Journal of Australia. 144(7). 347–350. 4 indexed citations
15.
Kwan, Yiu‐Lam, et al.. (1977). Metamorphosis of chronic granulocytic leukaemia arising in an extramedullary site. Leukemia Research. 1(4). 301–307. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul‐André Bryon Breakdown of academic impact, for papers by Jens Krugmann Breakdown of academic impact, for papers by Karin E. Summers Breakdown of academic impact, for papers by Suguru Fukuhara Breakdown of academic impact, for papers by Matteo Dell’Olio Breakdown of academic impact, for papers by Martin Dreyling Breakdown of academic impact, for papers by Flora N. Kontopidou Breakdown of academic impact, for papers by Olivier Fitoussi Breakdown of academic impact, for papers by J Pierson Breakdown of academic impact, for papers by Emmanuelle Nicolas‐Virelizier
Rankless by CCL
2026